Perfil da atividade de ectonucleotidases em plaquetas e agregação plaquetária em pacientes com lúpus eritematosos sistêmico

• Autor(a) principal: Rosa, Cíntia Saydelles da
• Data de Publicação: 2010
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações do UFSM
• Texto Completo: http://repositorio.ufsm.br/handle/1/11128
• topic: LES; Aterosclerose; Plaquetas; NTPDase; E-NPP; ADA; Agregação plaquetária; Systemic Lupus Erythematosus; Atherosclerosis; Platelets; ENPP; Platelets aggregation; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA

Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease that affects mostly women in reproductive age and sometimes cause permanent damage. The development of cardiovascular disease, especially atherosclerosis, is the leading cause of death in SLE. However, its etiology and relationship with the development of atherosclerosis remain unknown. Several studies have shown that platelets have relevant properties to thrombogenesis, such as the release of ADP, a molecule capable of inducing platelet aggregation. Adenosine, derived from the hydrolysis of ATP and ADP, in turn has antiagreggant properties. The control of extracellular levels theses molecules and subsequent purinergic signaling induced by them is carried out by enzymes NTPDase, E-NPP, 5'-nucleotidase and ADA. Therefore, the objective of this study was to evaluate the activity of these ectonucleotidases in platelets and platelet aggregation profile in patients with LES. An increase in the activity of the enzymes NTPDase, E-NPP, 5'-nucleotidase and ADA was observed in platelets of patients with lupus compared with control subjects. No difference on platelet aggregation of patients with lupus was observed when compared to control. The increase in activity of E-NTPDase, E-NPP and 5'-nucleotidase seems to be a compensatory organic response against the pathological condition, to generate higher concentration of adenosine. But the ADA activity also is increased in platelets of patients with SLE and may decrease the concentration of adenosine, which favors prothrombotics process. Thus, the results suggest that the ectoenzymes may be involved in the modulation of atherosclerotic processes that occur in SLE.